Cross Country Healthcare to be Acquired by Knox Lane for $437 Million in All-Cash Deal
Summary
Cross Country Healthcare has entered into a definitive agreement to be acquired by Knox Lane for $13.25 per share in an all-cash transaction valued at $437 million, representing a significant premium.
Key Events
-
Definitive Merger Agreement
Cross Country Healthcare will be acquired by Knox Lane for $13.25 per share in cash, totaling $437 million.
-
Significant Acquisition Premium
The offer price represents a 31% premium to the prior day's closing price and a 45% premium to the 90-day volume-weighted average price.
-
Delisting and Privatization
Upon completion, the company will become a privately held platform company in Knox Lane's portfolio and will cease trading on Nasdaq.
-
Canceled Corporate Events
The Q1 2026 earnings conference call and the 2026 Annual Meeting of Stockholders have been canceled due to the proposed merger.
Analysis
This DEFA14A filing officially confirms the definitive merger agreement for Cross Country Healthcare to be acquired by Knox Lane for $13.25 per share in cash, valuing the company at $437 million. This represents a significant premium to recent trading prices. The acquisition will result in the company becoming privately held and delisted from Nasdaq. The company has also canceled its Q1 2026 earnings call and 2026 Annual Meeting, underscoring the finality of the transaction. This event fundamentally alters the investment thesis for current shareholders, offering a substantial cash exit.
At the time of this filing, CCRN was trading at $12.94 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $326.7M. The 52-week trading range was $7.43 to $14.99. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.